This page includes the latest FDA filings for Sequenom Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
SEQUENOM, INC. | IMPACT DX FACTOR V LEIDEN AND FACTOR II GENOTYPING TEST | 2014-06-13 |
| NCAGE Code | 3SBS1 | SEQUENOM, INC. |
| CAGE Code | 3SBS1 | SEQUENOM, INC. |
| SEC | 0001076481 | SEQUENOM INC of DELAWARE |